AI Networking Cookbook: Practical recipes for AI-assisted network automation and development
TL;DR
These results demonstrate that liposomal peptide formulations are an effective strategy for enhancing the immunogenicity of HCV B-cell epitopes and provide a promising foundation for the development of a multi-epitope hepatitis C vaccine.
Hepatitis E virus (HEV) is one of the leading causes of acute and chronic hepatitis among humans across the globe and is linked to severe diseases in immunocompromised individuals and pregnant women. Despite its substantial global burden, only one vaccine is licensed (in China and Pakistan), limiting its global acc...
A major goal for hepatitis C virus (HCV) vaccine development is to elicit broadly neutralizing antibodies (bNAbs) against the E1E2 glycoprotein complex located on the viral surface. Inducing HCV bNAbs requires engagement of their germline B cell precursors. HCV glycoproteins usually do not bind and activate inferred ge...
Dengue virus (DENV) remains a major global health burden, with four antigenically distinct serotypes (DENV-1–4) posing a significant challenge for vaccine development. Dengue non-structural protein 1 (NS1) has been associated with protective immune responses and reduced disease severity, supporting its inclusion in vac...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.